Sean Maduck, President of Corcept Endocrinology, on May 27, 2026, sold 75,000 shares in Corcept Therapeutics (CORT) for $4,918,944. Following the Form 4 filing with the SEC, Maduck has control over a total of 118,694 common shares of the company, with 8,977 shares held directly and 109,717 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000119312526248967/xslF345X05/ownership.xml
Stacey G Rock, President, Kratos Turbine Technologies Division, on May 28, 2026, sold 4,000 shares in Kratos Defense & Security Solutions (KTOS) for $261,872. Following the Form 4 filing with the SEC, Rock has control over a total of 13,896 common shares of the company, with 13,896 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1069258/000134201726000007/xslF345X05/primary_doc.xml
John Farahi, 10% Owner, Director, CEO, on May 28, 2026, sold 5,000 shares in Monarch Casino & Resort (MCRI) for $604,200. Following the Form 4 filing with the SEC, Farahi has control over a total of 3,137,971 common shares of the company, with 616,556 shares held directly and 2,521,415 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/907242/000090724226000012/xslF345X05/primary_doc.xml
Todd P. Kelsey, Director, President & CEO, on May 27, 2026, sold 1,000 shares in Plexus (PLXS) for $274,750. Following the Form 4 filing with the SEC, Kelsey has control over a total of 71,388 common shares of the company, with 71,388 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785786/000141128226000014/xslF345X05/wk-form4_1780090720.xml